DalsnaFinance › Analyst accuracy › All targets
Every price target we have verified from published news, newest first: 106 targets from Mizuho. Each one shows the article it came from and links to its full entry, and is judged on the close on the date it comes due. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target.
Showing targets from Mizuho only. All targets Mizuho’s record →
Mizuho upgraded Viking Holdings (NYSE:VIK) to Outperform from Underperform and raised its price target to $120 from $82
Meanwhile, Mizuho also adjusted its price target for Haemonetics, increasing it to $165 from $140
Mizuho raised its price target on Costco Wholesale (NASDAQ:COST) to $1,100 from $1,065
Mizuho revised its target to $17.00 from $22.00, keeping an Outperform rating.
Mizuho raised its target price for Walmart to $135 from $125.
Mizuho lowered its price target on D-Wave Quantum Inc. (NASDAQ:QBTS) to $23 from $29
Mizuho reiterated an Outperform rating and $15.00 price target on Sunrun Inc.
Mizuho reiterated an Outperform rating and $27.00 price target on Corvus Pharmaceuticals
to $65 from $55 while maintaining an Outperform rating
Mizuho raised its price target on Tandem Diabetes Care shares (NASDAQ:TNDM) to $20 from $18 while maintaining a Neutral rating.
Mizuho raised its price target on Airbnb Inc. (NASDAQ:ABNB) to $245 from $200 while maintaining an Outperform rating.
Investing.com - Mizuho raised its price target on Livanova PLC shares (NASDAQ:LIVN) to $115 from $95 on Wednesday while maintaining an Outperform rating.
Mizuho raised its price target on Procore Technologies, Inc (NYSE:PCOR) to $68 from $55 while maintaining a Neutral rating on the stock.
Mizuho lowered its price target on Mosaic Co. (NYSE:MOS) to $20 from $22 while maintaining a Neutral rating
Mizuho lowered its price target on Super Micro Computer shares (NASDAQ:SMCI) to $36 from $43 while maintaining a Neutral rating, the firm said Tuesday.
Mizuho reiterated an Outperform rating and $120.00 price target on CVS Health
Mizuho reiterated an Outperform rating on Toast Inc. (NYSE:TOST) and maintained a $38.00 price target on the shares.
Mizuho reiterated an Outperform rating and $485.00 price target on Eaton Corporation
Mizuho raised its price target on Pinnacle West Capital (NYSE:PNW) to $109 from $103
Mizuho reiterated an Outperform rating and $245.00 price target on Palantir Technologies Inc. (NASDAQ:PLTR) following the company's third-quarter results.
to $1,132 from $1,140 while maintaining an Outperform rating
Mizuho raised its price target on Willis Towers Watson shares (NASDAQ:WTW) to $370 from $349
Mizuho raised its price target on AXIS Capital Holdings stock (NYSE:AXS) to $123 from $116 on Monday
to $328 from $324 on Monday while maintaining an Outperform rating.
Mizuho raised its price target on Tenet Healthcare shares (NYSE:THC) to $305 from $290 while maintaining an Outperform rating.
Mizuho lowered its price target on Edison International (NYSE:EIX) to $63 from $70 while maintaining a Neutral rating on the stock.
Mizuho raises Dominion Energy stock price target to $68 on earnings beat
Mizuho initiated coverage on H2O America Inc. (NASDAQ:HTO) with an Outperform rating and set a price target of $67.00
Mizuho initiated coverage on Janus Living Inc. (NASDAQ:JAN) with an outperform rating and set a price target of $33.00
Mizuho also cut its price target to $50 from $55, highlighting a reduction in the company's fiscal 2026 organic growth outlook to around 3.75% year-over-year.
Mizuho raised its price target on Linde stock (NASDAQ:LIN) to $583 from $575 while maintaining an Outperform rating
Mizuho initiated coverage on Castle Biosciences Inc. (NASDAQ:CSTL) with an Outperform rating and a price target of $60.00.
Mizuho lowered its price target on Jersey Mike’s Subs shares (NYSE:JMKE) to $27 from $29 while maintaining an Outperform rating.
Mizuho lowered its price target on Lennox International shares (NYSE:LII) to $350 from $395 while maintaining a Neutral rating
Mizuho raised its price target on Veeva Systems shares (NYSE:VEEV) to $345 from $280 while maintaining an Outperform rating.
Mizuho upgraded Hilton Worldwide (NYSE:HLT) to Outperform from Neutral on Thursday and raised its price target to $421
Mizuho reiterated a Neutral rating on American Electric Power
Mizuho maintained a Neutral rating with a $115 target, noting a decline in the international Diabetes segment due to competitive pricing pressures.
Mizuho reiterated its Outperform rating and $195 price target
According to TheFly, Mizuho kept an 'Underperform' rating on the stock and cut the price target to $43 from $45.
Mizuho reiterated an Outperform rating and $351.00 price target on Bloom Energy Corp.
UNH Maintained by Mizuho -- Price Target Raised to $500
This week, investment group Mizuho raised its 2027 profit forecast for SpaceX by more than $36 billion which is a 57% jump from their previous forecast. But their SpaceX stock price target only went up $5 from $200 to $205.
Mizuho lowered its price target on Six Flags Entertainment (NYSE:FUN) to $5.00 from $10.00
Mizuho raised its price target on Neptune Insurance Holdings (NYSE:NP) to $33 from $31 on Tuesday
Mizuho downgraded Braze Inc (NASDAQ:BRZE) to Neutral from Outperform and raised its price target to $47.50 from $32.00
Mizuho lifted its target to $600 from $510 after channel checks it called “very healthy overall,” while Citi raised its target to $636 from $600, citing survey and reseller checks that point to faster growth in productivity software and public cloud.
Mizuho bumped its target to $165 with an Outperform, and BMO took theirs to $170, also with an Outperform rating.
Investing.com - Mizuho upgraded Array Technologies (NASDAQ:ARRY) to Outperform from Neutral on Thursday while lowering its price target to $5.00 from $7.00.
lowered its price target on Range Resources (NYSE:RRC) to $52 from $55
Retracted targets, ones we found we had misreported, are not listed here and count toward nothing; each firm's row on the analyst accuracy page lists its own under "Retracted". These are facts about what each firm published, not recommendations from Dalsna Finance.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.